What is optical atrophy?

Optical atrophy is the condition of the eyes that causes loss of vision in different degrees, depending on the type of atrophy and the individual condition of the patient. The most common symptom of this eye disorder is the loss of vision and there is very rarely any pain associated with the disease. Some patients notice little changes in their vision, while others experience a serious loss. There are two main types of optical atrophy, obtained and congenital, which lead to loss of vision, even if other characteristics such as starting time are different. Treatment options are limited, but scientists are looking for ways to fight optical nerve damage. Optical nerves are technically part of the brain and therefore cannot regenerate as soon as they start the process. Any kind of damage to the optical nerve is usually irreversible apatients with this disease have experienced a medium to severe loss of vision after the onset of.

with obtained optical atrophy has a patient some tYP of the basic state that started an optical nerve failure. Any health condition that limits blood or oxygen flow to the optical nerve can lead to obtained optical atrophy, as well as optical nerve inflammation. Patients suffering from tumors exerting pressure on the nerve as well as deficiencies of vitamin B12 may also be at higher risk. In some cases, this type of eye disorder is the result of existing metabolic conditions such as diabetes mellitus and glaucoma.

There are two types of hereditary optical atrophy, known as the dominant optical atrophy and leber atrophy. In the case of dominant optical atrophy, affected patients are likely to experience loss of vision in early childhood, while the symptoms associated with leber disorder usually manifest aged between 20 and 30 years. Almost every case of leber atrophy affects only men because it passes exclusively through maternal genes to male children. The mutation that causes this condition affects the mitochondrial genome isDituble cells of the optical nerve.

Medical care and treatment of these conditions are limited and it is assumed that early diagnosis can be useful in stopping any further nerve damage. In most cases, the atrophy obtained may be prescribed that fights compression or toxicity, causing the original degeneration of the optical nerve. Scientists have begun to examine the treatment of stem cells in cases of optical atrophy and other neurological disorders with some success.